中药肝复乐配合介入治疗晚期肝癌疗效观察  

Clinical Observation on Advanced Primary Hepatic Cancer Treated by Chinese Herbs Ganfuluo with Intervention for the Treatment

作　　者：张逸群[1] 曾继泽[1] 何年馨[1] 

机构地区：[1]贵州遵义医学院肿瘤科,563003

出　　处：《中国肿瘤临床与康复》1998年第4期76-77,共2页Chinese Journal of Clinical Oncology and Rehabilitation

摘　　要：目的 :探讨晚期肝癌较为理想的综合治疗方法 ,提高患者生存质量。方法 :动脉导管内介入治疗前后服用中药制剂肝复乐。结果 :肝复乐配合化疗能改善因肝硬化或肝癌引起的临床症状和肝功能异常 ,降低 AFP。有效率为 6 6 .7% ,6、12和 18个月的生存率分别是 77.8% ,5 5 .6 %和 11.1%。结论 :肝复乐片对化疗有减毒增效作用 ,能有效地提高患者的生存质量。Objective:To investigate an ideal combination treatment and to improve the life quality of the survival patients of advanced primary hepatic carcinoma (PHC).Methods:9 cases were treated with Ganfuluo before and after treatment with transcatheter arterial infusion chemo therapy.Results:Ganfuluo combined chemotherapy can improve the clinical symptoms and hepatic function in cirrhosis and hepatic cancer,reduction of AFP.The effective rate in the treatment group was 66.7% and survival rates of 6、12 and 18 month were 77.8%、55.6% and 11.1% respectively.Conclusion:Ganfuluo tablets could enhance the efficacy and reduce the toxic side effect of chemotherapy.and could improve the quality of the patient's life.

关 键 词：原发性 肝癌 介入治疗 肝复乐 综合治疗 

分 类 号：R735.705[医药卫生—肿瘤]